# Predictive Oncology Inc. Predictive Oncology Inc. is an Asset Manager based in Pittsburgh, United States. ## Overview - **Organization type:** Asset Manager - **Headquarters:** Pittsburgh, United States - **Region:** North America - **Address:** 91 43rd Street Suite 110, Pittsburgh, PA 15201, United States - **Assets under management:** Undisclosed - **Website:** predictive-oncology.com ## Regulatory record - **Reports private funds:** No ## About Welcome to Predictive Oncology The leading edge of a new frontier in drug discovery Integrating scientific rigor with machine learning • Overcoming challenges of clinical trials • Improving the probability of success • Collaborating with partners in biopharma • Advancing molecules to medicine with confidence and accuracy Connect with us Changing the game in drug […] ## Sectors - AI/ML - Digital Health - Healthcare Services ## Questions ### Who runs investment decisions at Predictive Oncology? Predictive Oncology Inc. is a publicly traded company (NASDAQ: POAI) with a board of directors and executive management team. The firm does not disclose individual investment decision-makers publicly, and no named principals were found in available sources. ### How does Predictive Oncology source proprietary deal flow? Predictive Oncology sources proprietary deal flow through its offerings in drug discovery and clinical testing services. The company's biobank of over 150,000 tumor samples and its AI platform attract biopharma partners seeking drug-response testing and prediction, generating revenue from service contracts rather than venture-style investments. ### Does Predictive Oncology participate in fund commitments or only direct deals? Predictive Oncology does not participate in fund commitments. It is a service provider that uses its AI platform and tumor biobank to assist biopharma partners in drug development. The firm's revenue comes from service contracts, not from investing in external funds or making direct investments. ### What investment stages does Predictive Oncology typically target? Predictive Oncology is not an investment firm; it is a drug discovery and testing company. It targets the pre-clinical and early clinical development stages of the pharmaceutical pipeline, helping partners select drug candidates and predict efficacy before expensive clinical trials. ### Which sectors does Predictive Oncology explicitly avoid? Predictive Oncology explicitly focuses on oncology and drug discovery. The firm does not target sectors outside of cancer therapeutics and drug development, including no exposure to finance, real estate, or technology unrelated to healthcare. ## Related profiles - [EIT Health e.V.](https://altss.com/profile/eit-health-ev) - [Inception Fertility Holdings](https://altss.com/profile/inception-fertility-holdings) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/predictive-oncology-inc Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology